Skip to main content
. 2015 Oct 19;6(37):40186–40201. doi: 10.18632/oncotarget.5529

Table 1. Immune-specific cell-types (as per analysis in Bindea et al. [5]) for which a significant number of genes are up-regulated, and the genes up-regulated therein.

NvD DvT
Cell-type Genes Cell-type Genes
aDC LAMP3, OAS3 Macrophages MARCO, BCAT1, FN1, MSR1, SULT1C2, PCOLCE2, SCG5
B-cells BLK, KIAA0125, MS4A1, SCN3A, IGKC, SLC15A2, SPIB Neutrophils BST1, DYSF, FPR1, MME
Cytotoxic cells APBA2, GNLY, GZMA, NKG7, RUNX3 Tgd C1orf61, FEZ1
NK CD56 dim cells IL21R, GZMB Th1 cells DGKI, DOK5, EGFL6, GGT1
T-cells LCK, CD2, CD28, CD3D, CD3E, CD6, SH2D1A Th2 cells MB, ADCY1, PTGIS, ANK1, PHEX
TFH CXCL13, SIRPG, TOX
Th1 cells BST2, CD38, CTLA4

Abbreviations: NvD: Normal versus Dysplasia. DvT: Dysplasia versus Tumour. aDC: activated Dendritic Cell. TFH: T Follicular Helper cell. Th1/2: T-helper 1/2 cell. Tgd: T gamma delta cell.